Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
DLCL
DLCL

Dr Lalchandani Labs Ltd.

BSE: 541299
SME
Sector: Healthcare
Industry Group: Healthcare Services
6.96-0.2 (-2.66%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
6.01
P/E (TTM)
94.67
P/B
0.43
P/S (TTM)
1.44
EV/EBITDA
55.18
CAPE (5Y)
-
ROE (TTM)
0.53
ROCE (TTM)
-3.29
ROA (TTM)
0.38
Avg 3Y ROE
3.83
Earnings 3Y CAGR
-
Sales 3Y CAGR
-6.00
Sales 5Y CAGR
-
Debt/Equity
0.15
Consensus TP
-
Strong Buy %
-
Promoter Holding
-
Pledged %
-

Share Price

Track Dr Lalchandani Labs Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

6.96-0.2 (-2.66%)
-60.07% in past 1 year
1 Week returns: -0.43 %
Low
6.3
High
7.7
1 Month returns: -6.20 %
Low
5.8
High
7.7
1 Year returns: -60.07 %
Low
5.8
High
18.0
3 Year CAGR: -
Low
5.8
High
25.9
5 Year CAGR: -
Low
5.8
High
38.8
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Dr Lalchandani Labs Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative
Expensive and at a premium to industry median P/E

PE TTM of 94.67 indicates that the stock is expensive on a standalone basis and is at a 369.83% premium to industry median P/E

What is P/E Ratio?

Median: 20.15
Value 94.67
3.57344.87
Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral
Not enough talking points with neutral stance
Stock in GSM list
The stock has been places in Graded Surveillance Measure (GSM) list (GSM - 0).
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0192107.

Financial Snapshot

See detailed analysis

Multi-year trends for Dr Lalchandani Labs Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
00k0k0k5.0 CrMar 20234.8 CrMar 20244.5 CrMar 20254.2 CrMar 2026
Profit After Tax FY
-0k-0k-0k-0k00k0k-1.6 CrMar 20230.6 CrMar 20240.4 CrMar 20250.1 CrMar 2026
ROE FY
0%2%4%6%8%6.7%Mar 20244.3%Mar 20250.5%Mar 2026
EBITDA FY
00k0k0.1 CrMar 20230.2 CrMar 20240.9 CrMar 20250.1 CrMar 2026

Dr Lalchandani Labs Ltd. Shareholding Pattern

Quarterly breakdown of Dr Lalchandani Labs Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Mar 2017Sep 2018Mar 2019Sep 2019Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Dec 2025Mar 2026
Total Promoter
89.80
60.78
60.78
60.78
60.78
60.78
60.78
60.78
60.78
60.78
60.78
60.78
60.78
57.18
48.32
31.15
32.90
32.90
Indian Promoter
89.80
60.78
60.78
60.78
60.78
60.78
60.78
60.78
60.78
60.78
60.78
60.78
60.78
57.18
48.32
31.15
32.90
32.90
Foreign Promoter
0.00
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
0.00
-
-
-
-
-
-
-
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Mutual Funds / UTI
0.00
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
0.00
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non-Institution
10.20
39.22
39.22
39.22
39.22
39.22
39.22
39.22
39.22
39.22
39.22
39.22
39.22
42.82
51.68
68.85
67.10
67.10
Bodies Corporate
0.00
4.47
3.14
3.60
0.74
0.55
2.58
1.48
0.18
1.57
2.49
2.58
2.77
2.68
1.94
1.38
1.44
1.44
Others (incl. Retail)
No. of shareholders
10.20
0
34.75
159
36.08
144
35.62
138
38.48
137
38.67
139
36.64
135
37.74
144
39.04
153
37.65
156
36.73
157
36.64
152
36.45
158
40.14
174
49.74
239
67.47
200
65.66
226
65.66
225

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Dr Lalchandani Labs Ltd. shares as reported to NSE and BSE.

NameMonthTransactionHolding % pre transactionAverage priceQty.Transaction value
Arjan Lalchandani
Promoter
September-2025
Market Sale (Disposal)
8th Sep 2025
26.65 %₹ 0.0044.00 k₹ 1.00
Arjan Lalchandani
Promoter
September-2025
Market Sale (Disposal)
2nd Sep 2025
28.31 %₹ 0.0076.00 k₹ 2.00
Arjan Lalchandani
Promoter
August-2025
Market Sale (Disposal)
25th Aug 2025
29.70 %₹ 0.0060.00 k₹ 1.00
Arjan Lalchandani
Promoter
August-2025
Market Sale (Disposal)
19th Aug 2025
32.38 %₹ 19.001.16 lac₹ 22.04 lac
Arjan Lalchandani
Promoter
July-2025
Market Sale (Disposal)
5th Jul 2025
32.84 %₹ 20.148.00 k₹ 1.61 lac
Arjan Lalchandani
Promoter
July-2025
Market Sale (Disposal)
5th Jul 2025
33.30 %₹ 19.7720.00 k₹ 3.95 lac
Arjan Lalchandani
Promoter
July-2025
Market Sale (Disposal)
5th Jul 2025
33.76 %₹ 19.3920.00 k₹ 3.88 lac
Arjan Lalchandani
Promoter
July-2025
Market Sale (Disposal)
5th Jul 2025
32.65 %₹ 20.914.00 k₹ 83.64 k
Arjan Lalchandani
Promoter
July-2025
Market Sale (Disposal)
5th Jul 2025
32.56 %₹ 21.004.00 k₹ 84.00 k
Arjan Lalchandani
Promoter
June-2025
Market Sale (Disposal)
27th Jun 2025
35.70 %₹ 17.5820.00 k₹ 3.52 lac
…

Corporate Actions

History of Dr Lalchandani Labs Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

  1. Rights Issue(1 new shares @ ₹10 for 1 existing shares)
    Ex-date: 27th Jan 2026Announced on: 20th Jan 2026
    "Rights ISIN INE871Z20013 CINS Y2R0H2123 SEDOL BTQL0Q5."

Company Profile

Overview of Dr Lalchandani Labs Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Dr Lalchandani Labs Limited is an India-based company, which is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology...
Key personnel
Dr. Arjan LalchandaniD
Executive Chairman of the Board, Managing Director
Mr. Mohit LalchandaniD
Chief Executive Officer, Whole Time Director
Mrs. Anchal GuptaD
Chief Financial Officer, Executive Director
Mrs. Swati ChandraD
Non-Executive Director
Mr. Rajiv HandaD
Independent Director
Mr. Prakash JhuraneyD
Independent Director
Mr. Mohan Lal GandhiD
Non-Executive Independent Director
Mr. Mohan Lal GandhiD
Non-Executive Independent Director
Incorporated on
02 Aug 2017
Last Annual
31 Mar 2026
Last Interim
31 Mar 2026
No. of Employees
-
IPO date
09 May 2018
Free Float
24,97,258
Address
-

Frequently Asked Questions

What is the current share price of Dr Lalchandani Labs Ltd.?
The current share price of Dr Lalchandani Labs Ltd. is ₹ 6.96 as of 23 Oct 2026.
What is the market capitalisation of Dr Lalchandani Labs Ltd.?
The market capitalisation of Dr Lalchandani Labs Ltd. stands at ₹ 6.01 Cr.
What is the PE ratio of Dr Lalchandani Labs Ltd.?
The Price-to-Earnings (PE) ratio of Dr Lalchandani Labs Ltd. is 94.67 as of the latest trailing twelve months data.
What is the ROE and ROCE of Dr Lalchandani Labs Ltd.?
Dr Lalchandani Labs Ltd. has a Return on Equity (ROE) of 0.53% and a Return on Capital Employed (ROCE) of -3.29% as per the latest financial reports.
What is the 52-week high and low of Dr Lalchandani Labs Ltd.?
The 52-week high of Dr Lalchandani Labs Ltd. is - and the 52-week low is -.
What is the dividend yield of Dr Lalchandani Labs Ltd.?
The dividend yield of Dr Lalchandani Labs Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Dr Lalchandani Labs Ltd.?
Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of Dr Lalchandani Labs Ltd. shares.
What sector does Dr Lalchandani Labs Ltd. belong to?
Dr Lalchandani Labs Ltd. operates in the Healthcare sector.
What is the beta of Dr Lalchandani Labs Ltd.?
The beta of Dr Lalchandani Labs Ltd. is 0.26, indicating its price volatility relative to the broader market.
What is the RSI of Dr Lalchandani Labs Ltd.?
The 14-day Relative Strength Index (RSI) of Dr Lalchandani Labs Ltd. is 46.19, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.